Thomas & Salma Haider Biomedical Breakthrough Lecture
Second Annual Lecture on October 3, 2019 Features David Hafler, M.D. of the Yale School of Medicine
The annual Thomas & Salma Haider Biomedical Breakthrough Lecture brings the best and brightest researchers in the biomedical field to Riverside to present their research. The 2019 lecture will feature David Hafler, M.D. of the Yale School of Medicine and will be held on Thursday, October 3, 2019 at 6 p.m. at the UC Riverside Alumni and Visitors Center.
This annual lecture series is supported through the generosity of an endowed gift from Dr. Thomas and Salma Haider, longtime supporters of medical education and research at the University of California, Riverside.
Hafler is the William S. and Lois Stiles Edgerly professor and chairman Department of Neurology and professor of immunobiology at the Yale School of Medicine. He is the neurologist-in-chief of the Yale-New Haven Hospital. He is a clinical scientist with a research interest in the mechanism of multiple sclerosis with over 400 publications in the field of MS, autoimmunity and immunology and is a co-founder of the International Multiple Sclerosis Genetic Consortium a group that identified the genes causing MS.
The lecture is free and open to the public, though seating is limited and registration is required. Complimentary parking will be available in Lot 24.
When: Thursday, October 3, 2019 at 6:00 p.m.
Where: UC Riverside Alumni and Visitors Center
3701 Canyon Crest Dr., Riverside
Cost: Free and open to the public. Registration requested.
Parking: Complementary parking available in Lot 24 with registration
Questions: Email firstname.lastname@example.org
About David A. Hafler, M.D., F.A.N.A.
William S. & Lois Stiles Edgerly Professor & Chairman, Department of Neurology, & Professor of Immunobiology, Yale School of Medicine
Neurologist-in-Chief, Yale-New Haven Hospital
David A. Hafler, M.D., F.A.N.A. is the William S. and Lois Stiles Edgerly professor and chairman Department of Neurology and professor of Immunobiology, Yale School of Medicine, and is the neurologist-in-chief of the Yale-New Haven Hospital.
Hafler is a clinical scientist with a research interest in the mechanism of multiple sclerosis (MS) with over 400 publications in the fields of MS, autoimmunity and immunology. He is a co-founder of the International MS Genetic Consortium a group that identified the genes causing MS. He has served as a member of the editorial boards for Journal of Clinical Investigation and the Journal of Experimental Medicine, and is co-founder of the Federation of Clinical Immunology Societies and leads the NIH Autoimmunity Prevention Center Grant at Yale.
Hafler graduated magna cum laude in 1974 from Emory University with combined B.S. and M.Sc. degrees in biochemistry, and the University of Miami School of Medicine in 1978. He completed his internship in internal medicine at Johns Hopkins followed by a neurology residency at Cornell Medical Center-New York Hospital in New York. He was trained in immunology at the Rockefeller University and then at Harvard.
He joined the Harvard faculty in 1984 and later became the Breakstone professorship of neurology. He was a founding associated member of the Broad Institute at MIT. In 2009 he moved to Yale as the chair of the Department of Neurology.
His awards include the Jacob Javits Merit Award from the National Institutes of Health, the Dystel Prize for MS research from the American Academy of Neurology, the University of Miami Annual Distinguished Alumni Award, and the Raymond Adams Prize from the American Neurologic Association. Hafler has been elected to membership in the Alpha Omega Society, the American Society of Clinical Investigation, and the National Academy of Medicine.
2018: Susan L. Akerman, Ph.D.
Professor of Cellular and Molecular Medicine, and the Stephen W. Kuffler Chair in Biology, at the University of California, San Diego